|
|
Article: OTHER NEWS TO NOTE.(various companies and corporate activities)(Statistical Data Included)
- Article from:
- BIOWORLD Today
- Article date:
- September 28, 2001
CopyrightCOPYRIGHT 2001 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bioqual Inc., of Rockville, Md., was awarded a two-year, $738,847 Phase II SBIR grant, effective Sept. 30, for a study titled "Comparative DNA Sequence Variation in Alzheimer Genes." Bioqual researchers will use biochemical assays to identify aged, living chimpanzees with dementia or other age-related disorders. They then will search for disease-causing mutations in the chimps, as well as in archival chimpanzee brain tissue samples having Alzheimer's-related neuropathology.
Cellzome GmbH, of Heidelberg, Germany, acquired UK-based Cell Map, a division of GlaxoSmithKline plc (GSK), of London. Cell Map is focused on mapping protein-protein interactions in the ...